Amiloride disposition in geriatric patients: importance of renal function
- PMID: 2297454
- PMCID: PMC1380054
- DOI: 10.1111/j.1365-2125.1990.tb03595.x
Amiloride disposition in geriatric patients: importance of renal function
Abstract
1. The absorption and disposition of the potassium sparing diuretic amiloride were determined in nine elderly patients aged 71 to 87 years and in eight young (25 to 38 years) subjects following oral administration of 5 mg amiloride HCl daily to steady-state. 2. The maximum and steady-state plasma amiloride concentrations were significantly (P less than 0.05 and P less than 0.001) higher in the elderly patients. The renal clearance of amiloride was lower in the elderly than in young subjects (102 +/- 36 ml min -1 vs 300 +/- 64 ml min-1, P less than 0.001) as was the urinary excretion of amiloride (36 +/- 13 vs 62 +/- 18% of the dose, P less than 0.01). 3. The steady-state plasma amiloride concentration correlated significantly (r2 = 0.61, P less than 0.001) with amiloride renal clearance and with creatinine clearance (r2 = 0.59, P less than 0.001). There was a very strong positive correlation between renal amiloride clearance and creatinine clearance (r2 = 0.76, P less than 0.001). The slope of the regression line was 2.5 indicating substantial proximal tubular secretion of amiloride. 4. Sodium and potassium excretion, along with urine volume were significantly (P less than 0.05) lower in the elderly (by 39, 45 and 34% respectively). 5. The disposition of amiloride was highly dependent on renal function, with higher plasma amiloride concentrations in the elderly reflecting diminished renal function. The dose of amiloride should be titrated to individual response, and the lower potassium excretion in the elderly patients suggests that the dose of amiloride could be reduced in this group of patients.
Similar articles
-
The pharmacokinetics of amiloride-hydrochlorothiazide combination in the young and elderly.Eur J Clin Pharmacol. 1989;37(2):167-71. doi: 10.1007/BF00558226. Eur J Clin Pharmacol. 1989. PMID: 2792171
-
Renal tubular secretion of amiloride and its inhibition by cimetidine in humans and in an animal model.Drug Metab Dispos. 1989 Mar-Apr;17(2):190-6. Drug Metab Dispos. 1989. PMID: 2565210 Clinical Trial.
-
Aging effects on the organic base transporter and stereoselective renal clearance.Clin Pharmacol Ther. 1997 Aug;62(2):117-28. doi: 10.1016/S0009-9236(97)90059-X. Clin Pharmacol Ther. 1997. PMID: 9284847 Clinical Trial.
-
Pharmacokinetics of amiloride in renal and hepatic disease.Eur J Clin Pharmacol. 1987;33(5):493-8. doi: 10.1007/BF00544242. Eur J Clin Pharmacol. 1987. PMID: 3428342
-
Effects of diuretics on the renal handling of magnesium.Drugs. 1984 Oct;28 Suppl 1:167-81. doi: 10.2165/00003495-198400281-00017. Drugs. 1984. PMID: 6389077 Review.
Cited by
-
Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.Drugs Aging. 1991 May;1(3):194-211. doi: 10.2165/00002512-199101030-00004. Drugs Aging. 1991. PMID: 1686570 Review.
-
Drug dosage in the elderly. Is it rational?Drugs Aging. 1998 Nov;13(5):357-79. doi: 10.2165/00002512-199813050-00003. Drugs Aging. 1998. PMID: 9829164 Review.
-
Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.Br J Clin Pharmacol. 2004 Jan;57(1):6-14. doi: 10.1046/j.1365-2125.2003.02007.x. Br J Clin Pharmacol. 2004. PMID: 14678335 Free PMC article. Review.
-
Age-related modifications in CYP-dependent drug metabolism: role of stress.Front Endocrinol (Lausanne). 2023 May 24;14:1143835. doi: 10.3389/fendo.2023.1143835. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37293497 Free PMC article. Review.
-
Adverse drug reactions. An overview of special considerations in the management of the elderly patient.Drug Saf. 1990 Nov-Dec;5(6):421-35. doi: 10.2165/00002018-199005060-00003. Drug Saf. 1990. PMID: 2285496 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous